SureTrader
Home > Boards > US Listed > Medical - Drugs > Nektar Therapeutics (NKTR)

Bad link... try this one for AMLN [#msg-10433899]

Public Reply | Private Reply | Keep | Last ReadPost New MsgNext 10 | Previous | Next
SeriousMoney Member Profile
 
Followed By 30
Posts 7,965
Boards Moderated 5
Alias Born 04/05/05
160x600 placeholder
Advertisement
Statement of Changes in Beneficial Ownership (4) "Edgar (US Regulatory)" - 7/1/2015 4:10:51 PM
Columbia Pipeline to Join the S&P 500; Other Changes to S&P MidCap 400 & S&P SmallCap 600 "PR Newswire (US)" - 6/24/2015 7:28:00 AM
Statement of Changes in Beneficial Ownership (4) "Edgar (US Regulatory)" - 6/23/2015 4:07:42 PM
Current Report Filing (8-k) "Edgar (US Regulatory)" - 6/17/2015 4:23:34 PM
Statement of Changes in Beneficial Ownership (4) "Edgar (US Regulatory)" - 6/17/2015 4:09:08 PM
Nektar and MD Anderson Cancer Center Announce Phase 1/2 Clinical Research Collaboration for NKTR-214, a CD122-Biased Immuno-S... "PR Newswire (US)" - 6/2/2015 8:00:00 AM
Nektar Therapeutics' President and CEO, Howard W. Robin, To Present at the Jefferies 2015 Global Healthcare Conference in New... "PR Newswire (US)" - 5/28/2015 9:15:00 AM
Nektar Therapeutics Upgraded at Zacks (NKTR) "Analyst Ratings Network" - 5/6/2015 11:03:43 AM
Nektar Therapeutics Raised to Hold at TheStreet (NKTR) "Analyst Ratings Network" - 5/1/2015 6:16:44 PM
Why Shares of Nektar Therapeutics Are Buzzing Today "The Motley Fool" - 5/1/2015 2:41:26 PM
Quarterly Report (10-q) "Edgar (US Regulatory)" - 5/1/2015 6:25:39 AM
Additional Proxy Soliciting Materials (definitive) (defa14a) "Edgar (US Regulatory)" - 4/30/2015 5:31:34 PM
Proxy Statement (definitive) (def 14a) "Edgar (US Regulatory)" - 4/30/2015 5:27:39 PM
Current Report Filing (8-k) "Edgar (US Regulatory)" - 4/30/2015 5:19:14 PM
Amended Annual Report (10-k/a) "Edgar (US Regulatory)" - 4/30/2015 5:16:51 PM
Nektar Therapeutics Reports Financial Results for the First Quarter of 2015 "PR Newswire (US)" - 4/30/2015 4:15:00 PM
Nektar to Announce Financial Results for the First Quarter 2015 on Thursday, April 30, 2015, After Close of U.S.-Based Financ... "PR Newswire (US)" - 4/23/2015 4:15:00 PM
Baxter Submits Application To Japan's MHLW For Approval Of BAX 855, Extended Half-Life Recombinant FVIII Based On ADVATE For ... "PR Newswire (US)" - 4/16/2015 9:14:00 AM
Nektar Therapeutics to Present at the 14th Annual Needham Healthcare Conference "PR Newswire (US)" - 4/13/2015 4:15:00 PM
Nektar Announces Receipt of $100 Million Milestone Payment from AstraZeneca "PR Newswire (US)" - 4/2/2015 9:35:00 AM
MOVANTIK™ (Naloxegol) Tablets For The Treatment Of Opioid-Induced Constipation In Adult Patients With Chronic Non-Cancer Pa... "PR Newswire (US)" - 3/31/2015 9:10:00 AM
AstraZeneca And Daiichi Sankyo To Jointly Commercialise MOVANTIK In The US "PR Newswire (US)" - 3/19/2015 8:30:00 AM
Bernstein Liebhard LLP Investigates Claims On Behalf Of Those Who Invested In Nektar Therapeutics "PR Newswire (US)" - 3/18/2015 3:53:00 PM
Why Nektar Therapeutics Stock Slumped Today "The Motley Fool" - 3/18/2015 11:56:43 AM
Current Report Filing (8-k) "Edgar (US Regulatory)" - 3/17/2015 5:30:07 PM
Public Reply | Private Reply | Keep | Last ReadPost New MsgNext 10 | Previous | Next
Follow Board Follow Board Keyboard Shortcuts Report TOS Violation
X
Current Price
Change
Volume
Detailed Quote - Discussion Board
Intraday Chart
+/- to Watchlist